Drug Database
Back to search

Poland· PL-100370892

Clobetaxon

A clobetasol product containing clobetasoli propionas, registered in Poland by Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.. The same ATC class is registered in 16 of our 19 countries.

ATC D07AD01

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedClobetaxonATCD07AD01REGISTER NO.PL-100370892PACKS LISTED1CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about clobetasoli propionasAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Clobetasol is registered in 16 of 19 countries.

Countries holding a registration under ATC D07AD01 (clobetasol), each read from that country’s own register.

  • This record: Poland, from URPL (Poland)
  • 9 of them publish a price we can compare per daily dose
Search clobetasol products by name

Clobetasol · ATC D07AD01

16 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

URPL (Poland)
Active substance
Clobetasoli propionas
Manufacturer
Przedsiębiorstwo Produkcji Farmaceutycznej HASCO-LEK S.A.
Country
Poland (PL)
ATC code
D07AD01
ATC class
Clobetasol
Defined daily dose
0.5 mg, T
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 1

  • gtin
    05909991307196

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

273 interactions on record for clobetasol.

Graded by severity as the source publishes them — 55 minor. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check clobetasol against other medicinesHow interaction checks work

Clobetasol · interactions on record

273 records

  • 55 minor
  • 218 info

Most severe, free to view

    Mechanism and what to do, in the interaction check
    Interaction register. Grades as the source publishes them.

    Same medicine, other countries

    Clobetasol in 17 other countries

    What each register calls a product with the same active substance — salts and hydrates count as the same.

    All clobetasol products

    Authorised across Europe · EMA

    The same active substance is authorised in 28 EEA countries. Names it is sold under:

    • Austria · Clarelux, Clobex
    • Belgium · Cabesol, Clarelux
    • Bulgaria · Дермоват, Инфилеа
    • Cyprus · Dermovate, Medodermone
    • Czechia · Clarelux, Clobetasol Belupo
    • Germany · Clarelux, Clobegalen
    • Denmark · Clobetasol Propionate Ifc, Clobetasolpropionat
    • Estonia · Dermovate, Dermovate Ointment
    • Spain · Clarelux, Clobex
    • Finland · Clobex, Dermovat
    • France · Cabesol, Clarelux
    • United Kingdom (Northern Ireland) · Clarelux, Clobaderm
    • Greece · Butavate, Clarelux
    • Croatia · Cutibel
    • Hungary · Clobex, Closanasol
    • Ireland · Dermovate, Dermovate Scalp Application
    • Iceland · Clobex, Dermovat
    • Italy · Clobecare, Clobesol
    • Lithuania · Closanasol, Dermovate
    • Luxembourg · Cabesol, Clarelux
    • Malta · Clobex, Dermovate
    • Netherlands · Clarelux, Clobetasol Substipharm
    • Norway · Clobex, Dermovat
    • Portugal · Clarelux, Clobetasol Basi
    • Romania · Clobetasol Mk, Clobetazol Atb
    • Sweden · Clobetasol Teva, Clobex
    • Slovenia · Klobetazol Belupo
    • Slovakia · Clarelux, Clobetasol Belupo

    Source: European Medicines Agency, Article 57 product data.

    Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

    For developers

    The same record over the API, and the raw payload
    GET /v1/drugs/faf305dc-9861-42bf-9979-ab6f151e8ab4
GET /v1/drugs/faf305dc-9861-42bf-9979-ab6f151e8ab4?format=fhir

    Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

    {
  "form": "Maść",
  "source": "urpl",
  "strength": "0,5 mg/g",
  "packaging": "05909991307196 ¦ Rp ¦ 115894\n1 tuba 25 g",
  "substance": "Clobetasoli propionas 0.5 mg/g",
  "common_name": "Clobetasoli propionas",
  "pl_product_id": "100370892",
  "pozwolenie_nr": "23661",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
    API referenceMCP serverPlans

    See everything about clobetasol.

    This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

    Try it freeOpen in the console